Safety Profiles Related to Dosing Errors of Rapid-Acting Insulin Analogs: A Comparative Analysis Using the EudraVigilance Database
Although there were fewer dosing errors of RAIAs in comparison to other insulins, the severity of the potential outcome highlights the importance of precise dosing and timing. Improved the monitoring and reporting of these dosing errors could enhance diabetes patient care. Additionally, smart medical devices could improve therapeutic outcomes.
Authors
- Felicia Gabriela Gligor (ORCID: https://orcid.org/0000-0003-3167-9864)
- Andreea Loredana Vonica-Țincu (ORCID: https://orcid.org/0000-0001-6362-4302)
- Claudiu Morgovan (ORCID: https://orcid.org/0000-0003-2730-8729)
- Adina Frum (ORCID: https://orcid.org/0000-0003-4874-0430)
- Stéliana Ghibu (ORCID: https://orcid.org/0000-0003-2247-4613)
- Anca Butucă (ORCID: https://orcid.org/0000-0003-1540-641X)
- Carmen Maximiliana Dobrea (ORCID: https://orcid.org/0000-0002-9913-1750)
- Ioana Rada Popa Ilie (ORCID: https://orcid.org/0000-0002-5281-5004)
Institutions
- Lucian Blaga University of Sibiu (RO)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-10-07
- DOI
- https://doi.org/10.3390/biomedicines12102273
- Citations
- 2
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.72